Want to see SE:ACE full AI Analyst Report?
Ascelia Pharma AB (ACE) Financial Statements
Ascelia Pharma AB Financial Overview
Ascelia Pharma AB's market cap is currently $77.45M. The company's EPS TTM is $-0.48; its P/E ratio is -1.20; Ascelia Pharma AB has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -888.00K | $ -938.00K | $ -1.05M | $ -3.89M | $ -8.72M |
| Operating Income | $ -74.13M | $ -68.12M | $ -110.91M | $ -147.01M | $ -137.95M |
| EBITDA | $ -73.24M | $ -66.83M | $ -108.56M | $ -132.06M | $ -128.42M |
| Net Income | $ -76.25M | $ -80.03M | $ -109.29M | $ -131.22M | $ -125.90M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 49.86M | $ 75.26M | $ 21.86M | $ 149.56M | $ 261.60M |
| Total Assets | $ 111.94M | $ 140.92M | $ 87.07M | $ 218.57M | $ 333.49M |
| Total Debt | $ 1.04M | $ 25.40M | $ 1.06M | $ 484.00K | $ 1.66M |
| Net Debt | $ -48.82M | $ -49.86M | $ -20.80M | $ -149.07M | $ -259.94M |
| Total Liabilities | $ 12.47M | $ 61.98M | $ 12.74M | $ 37.71M | $ 25.66M |
| Stockholders' Equity | $ 99.47M | $ 78.94M | $ 74.33M | $ 180.86M | $ 307.83M |
| Cash Flow | |||||
| Free Cash Flow | $ -72.31M | $ -62.84M | $ -126.79M | $ -125.33M | $ -116.60M |
| Operating Cash Flow | $ -72.25M | $ -62.84M | $ -126.79M | $ -125.26M | $ -116.56M |
| Investing Cash Flow | $ -57.00K | $ 0.00 | $ 46.00K | $ -65.00K | $ -38.00K |
| Financing Cash Flow | $ 48.21M | $ 115.19M | $ -936.00K | $ -1.10K | $ 184.87M |
Currency in SEK